Bryony Simmons

Also affiliated with London School of Economics and Political Science

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase”.

Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase

Nature Communications(2020)10.1038/s41467-020-19801-x

N/A

4.0DataRank · unranked

83 citations

Michelle Moorhouse, Bryony Simmons, Túlio de Oliveira, Richard Lessells, Jennifer Giandhari +8 more

Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB): a phase 2, non-comparative, randomised controlled trial

The Lancet HIV(2023)10.1016/s2352-3018(23)00081-4

N/A

1.8DataRank · unranked

41 citations

Ying Zhao, Bryony Simmons, Zaayid Omar, Lubbe Wiesner, Claire Keene +4 more

Initial Supplementary Dose of Dolutegravir in Second-Line Antiretroviral Therapy: A Noncomparative, Double-Blind, Randomized Placebo-Controlled Trial

Clinical Infectious Diseases(2023)10.1093/cid/ciad023

N/A

0.422DataRank · unranked

7 citations

Rulan Griesel, Zaayid Omar, Bryony Simmons, Andrew Hill, Gert U. van Zyl +4 more